Kiran Mazumdar-Shaw of Biocon secured the fourth spot with Rs 29,330 crore, making a mark of India’s biotech and healthcare ...

September yields at least 23 listing applications from mainland biotech firms eyeing the city’s lucrative fundraising market.

If the U.S. stays on its current path, it will surrender its biotech lead not because China wins, but because Washington quits.

Englewood biotech SpotitEarly partners with Hackensack Meridian to study AI and canine-powered breath tests for early cancer ...

AbCellera (ABCL) has pivoted to in-house drug development, with two Phase 1 assets and a recent share price surge despite ...

Nanobiotix (NASDAQ:NBTX) traded higher on Thursday after the French biotech announced initial results from a Phase 1 trial ...

Patient advocacy groups asked the U.K.’s antitrust regulator to investigate several large drugmakers and their lobbying ...

A survey of biotech investors found that 86% believe that fewer than half of management teams communicate effectively, ...

Symbio Bioculinary does not concern submission combat or landscaping businesses, it upcycles food waste to tackle the over 30 ...

A Rockville clinical-stage biotech has closed a $50 million Series B round to advance its potential treatments for cancer and ...